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Abstract
Although neurological manifestations associated with dengue viruses (DENV) infection
have been reported, there is very limited information on the genetic characteristics of neuro-
tropic DENV. Here we describe the isolation and complete genome analysis of DENV sero-
type 3 (DENV-3) from cerebrospinal fluid of an encephalitis paediatric patient in Jakarta,
Indonesia. Next-generation sequencing was employed to deduce the complete genome of
the neurotropic DENV-3 isolate. Based on complete genome analysis, two unique and nine
uncommon amino acid changes in the protein coding region were observed in the virus. A
phylogenetic tree and molecular clock analysis revealed that the neurotropic virus was a
member of Sumatran-Javan clade of DENV-3 genotype I and shared a common ancestor
with other isolates from Jakarta around 1998. This is the first report of neurotropic DENV-3
complete genome analysis, providing detailed information on the genetic characteristics of
this virus.
Author summary
Dengue viruses (DENV) are viruses that can cause asymptomatic infection to life-threat-
ening haemorrhagic fever disease. Although DENV are not classically known to infect
and invade central nervous system (CNS) in human, numerous cases of DENV infection
in the CNS have been reported with limited information about the characteristics of
the infecting virus. Here, we report the isolation and first complete genome analysis of
DENV serotype 3 (DENV-3) from cerebrospinal fluid of a patient diagnosed with dengue
encephalitis in Jakarta, Indonesia. By using next-generation sequencing strategy, we
recovered the complete genome of the virus isolate and identified unique amino acid
changes not found in any other recovered DENV-3 strains. The virus was determined to
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be closely related to isolates from Jakarta, Indonesia, which have been circulating for
almost four decades.
Introduction
Dengue viruses (DENV) are among the most important mosquito-borne viruses from the
genus Flavivirus, family Flaviviridae and have been a major public health problem in many
parts of the world, including Southeast Asia and the Americas [1]. In Indonesia, DENV has
become a significant public health problem with a trend toward increasing numbers of out-
breaks [2–5]. Infection with any of the four DENV serotypes can be asymptomatic or cause a
spectrum of clinical symptoms from mild fever to a more severe, potentially life-threatening
disease including dengue haemorrhagic fever and shock syndrome [6]. Although DENV is not
a classical neurotropic virus, evidence of DENV neurotropism and neurological dengue have
increased over the past five decades [7]. In laboratory-confirmed cases of DENV infection
with admission to the hospital, the frequency of neurological involvement has ranged between
0.5% to 21%; while in patients admitted to the hospitals with encephalitis or suspected central
nervous system (CNS) infection, DENV was identified in 4-47% of patients in endemic areas
[7]. To address this expanding clinical manifestation of DENV infection, the latest WHO den-
gue guidelines published in 2011 have included CNS involvement in the definition of severe
disease [8]. Nevertheless, the molecular and biological characteristics of neurotropic DENV
strains is extremely limited despite its important role in deciphering the neuropathogenesis of
dengue. Here, we report the isolation and complete genome analysis of DENV-3 from the CSF
on a paediatric encephalitis patient in Jakarta, Indonesia.
Materials and methods
Ethics statement
Informed consent was obtained from the parents of the patient. The patient’s identity and per-
sonal information has been de-identified from the sample number, test results, or GenBank
accession number. The study was approved by the Eijkman Institute Research Ethic Commis-
sion (Ethical Approval No. 66).
Case description and DENV detection
In June 2016, a 10-year old boy was referred to Dr. Cipto Mangunkusumo National Central
Hospital, Jakarta, Indonesia with the chief complaint of decreased consciousness on the second
day of illness. He had history of high grade fever for two days accompanied with headache,
nausea, vomiting, seizures and altered consciousness before admission. His laboratory exami-
nation showed hemoconcentration, thrombocytopenia, positive anti-DENV serum IgM and
NS1 antigen, and normal blood chemistries. Lumbar puncture (LP) was performed on day two
post illness onset to obtain CSF sample from the patient. There was no evidence of blood in
the CSF indicating that the LP was not traumatic. The CSF was clear with 5 polymorphonu-
clear cells/μl, 2 mononuclear cells/μl, 60 mg/dl protein, 51 mg/dl glucose, and 121 mEq/l chlo-
ride. The patient was diagnosed with dengue encephalitis based on the neurological symptoms
and detection of anti-DENV antibody and NS1 antigen in serum and was given supportive
therapy. His consciousness improved on day 5 of illness after intensive supportive care and he
was discharged after 12 days without any neurological sequelae. The CSF sample (designated
as 201610225), was submitted to Eijkman Institute where it was analysed by using pan-alpha-
virus and pan-flavivirus RT-PCR targeting nSP4 and NS5 genes, respectively [9,10]. Pan-
DENV-3 encephalitis
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alphavirus RT-PCR was negative, while pan-flavivirus RT-PCR was positive. A flavivirus-spe-
cific 265-bp amplicon was sequenced from the sample and showed 99% nucleotide identity
with DENV-3 in subsequent BLAST analysis.
Further examination of the CSF and serum samples confirmed the presence of DENV-3
RNA by using Simplexa Dengue Real-time RT-PCR Kit (Focus Diagnostics, Cypress, CA). The
anti-dengue IgM and anti-dengue IgG (Panbio Dengue Duo IgM and IgG Capture ELISA,
Alere, Brisbane, Australia) were absent from CSF although the serum sample was DENV IgM-
positive/IgG-negative, suggesting a primary DENV infection. DENV NS1 antigen was detected
in the serum and CSF samples by using rapid NS1 detection kit (Panbio Dengue Early Rapid).
The DENV viral load was measured by using SYBR Green qRT-PCR as described previously
[11] and was estimated to be 19,800 and 975,000 PFU equivalent/ml in the CSF and serum
samples, respectively.
Virus isolation in cell culture and indirect immunofluorescent assay (IFA)
Virus isolation was performed by using Vero cells (African green monkey kidney epithelial) as
described previously [12]. Cell monolayers were inoculated with the CSF and serum samples
and incubated for 1 hour at 37˚C. Infected monolayers were subsequently maintained in
MEM medium supplemented with 10% FBS, 500 U/ml penicillin, 500 μg/ml streptomycin,
and 2 mM L-glutamine (Gibco, Carlsbad, CA). The presence of cytopathic effect (CPE) was
investigated daily and DENV-3 RNA in culture supernatant was detected by pan-flavivirus
RT-PCR and sequencing of the amplicon.
Virus isolation from CSF sample was also performed by using Aedes albopictus C6/36 cells.
Cell monolayer was inoculated with CSF sample and incubated for 1 hour at 28˚C and subse-
quently maintained in RPMI medium supplemented with 10% FBS, 500 U/ml penicillin,
500 μg/ml streptomycin, and 2 mM L-glutamine (Gibco). The presence of CPE was investi-
gated daily and DENV-3 infection was confirmed by IFA staining with anti-DENV-3 mono-
clonal antibody. In the absence of CPE within 10 days, culture supernatant was blind passaged
to new C6/36 cell monolayer. For IFA staining, infected C6/36 cells were spotted onto 12-well
Teflon coated slides, air-dried and then fixed in cold 100% acetone for 10 min. Fixed cells were
incubated with mouse anti-DENV-3 monoclonal antibody (clone 5D4) for 30 minutes at
37˚C, followed by FITC-conjugated goat anti-mouse IgG (Sigma, St. Louis, MO, USA) for 30
minutes at 37˚C. Cells were rinsed twice with PBS and counterstained with 0.05% Evans blue.
DENV full-genome analyses
Next-generation sequencing (NGS) was employed to sequence the complete DENV-3 RNA
genome from Vero cell culture supernatant by using Ovation RNA-Seq System V2 library
preparation kit (NuGEN, San Carlos, CA) according to the manufacturer’s recommendations.
The Ion PGM Hi-Q OT2 Kit (Life Technologies, Carlsbad, CA) was used to prepare and enrich
template-positive particles from the cDNA library. Enriched cDNA library was sequenced
using the Ion PGM sequencer, Ion PGM Hi-Q Sequencing Kit, and an Ion 316 Chip v2 BC.
Reads from the Ion PGM sequencer were dereplicated and filtered based on their quality
and length with PRINSEQ lite version (prinseq-lite.pl) [13], with following settings: -derep 5
-max_len 250 -min_len 125 -min_qual_mean 30. These settings were used to remove reverse
complement 5’/3’ duplicates as well as to screen for reads with Q>30 and length range 125–
250 bp. SPAdes assembler v.3.7.1 meta-mode [14] was used to assemble the filtered reads, with
following settings:--iontorrent -k 21,33,55 --meta.
The extreme 5’ and 3’UTR of the genome were obtained by Sanger sequencing using
DENV-3-specific primer sets as described previously [15]. The full length 10,707-nt sequence
DENV-3 encephalitis
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of DENV-3 strain 201610225 was annotated with Genome Annotator tools in Virus Pathogen
Database and Analysis Resource (ViPR, www.ViPRbrc.org).
DENV-3 sequence and phylogenetic analysis
The complete genome sequence of DENV-3 strain 201610225 was assembled and aligned
with DENV-3 prototype strain H87 and all available DENV-3 complete genome sequences
retrieved from the GenBank database with known host and country of isolation as of Decem-
ber 6, 2016 (n = 787) (S1 Table). Multiple sequence alignment was performed using MUSCLE
v.3.8 [16] and trimmed to generate a dataset of 10,170-nucleotide (3,390 amino acid) encoding
the complete DENV-3 open reading frame (ORF). The aligned sequences were used to analyse
amino acid sequence variation visualized in MEGA v.7.0.21.
The 3’UTR RNA secondary structures of 201610225 and prototype strain H87 were pre-
dicted using the Mfold web server (http://unafold.rna.albany.edu/?q=mfold) [17]. Mfold pre-
dictions were constrained to preserve consistency of RNA structures with bioinformatics and
biochemical predictions as described previously [18]. The optimal energy folding patterns
from the Mfold predictions were visualized with VARNA [19].
To identify representative and closely related reference sequences for deep phylogenetic
analysis, a maximum-likelihood phylogenetic tree was constructed from the initial alignment
by using FastTree v.2.1. The evolutionary history and the time to most common ancestor
(TMRCA) of strain 201610225 was analysed using Bayesian Markov chain Monte Carlo
(MCMC) method as implemented in BEAST v.1.7.4 [20]. The evolution model was evaluated
using jModelTest v.2.2.7 [21] and the generalised time reversible (GTR) model with invariant
and gamma sites (GTR+I+G) was used, as recommended by Akaike (AIC) and Bayesian infor-
mation criteria (BIC) from jModelTest output. BEAST analysis was subsequently performed
with following parameters: GTR+I+G, lognormal relaxed clock, uniform clock rate, coalescent
Bayesian skyride tree prior, and 50 million MCMC repetitions (sampling every 1,000 trees)
[22]. The collection of trees from this process was annotated using TreeAnnotator v.1.8.2 to
get the most credible tree. FigTree v1.2.2 was used to view and evaluate the most credible tree.
Similarly, for further grouping of 201610225 relative to other recent Indonesian DENV-3
strains, 112 available DENV-3 envelope gene sequences (1,479 nt) were analysed including
prototype reference strains for each DENV-3 genotype as well as recent Indonesian and South-
east Asian strains.
Amino acid changes mapping onto existing homologous structural data from Protein Data
Bank (PDB) was done by using FeatureMap3D (http://www.cbs.dtu.dk/services/) [23]. The
multiple sequence alignment dataset was also used to check for the presence of recombination
in our isolate by using the Recombination Detection Program version 4 (RDP4) which used
seven different recombination detection methods [24]. A sequence was considered as a poten-
tial recombinant only if it was detected as significant (with p-value cutoff of 0.00001) by at
least two methods.
Accession number
The complete genome sequence of DENV-3 isolate 201610225 is available in GenBank under
accession number KY863456.
Results
Neurotropic DENV-3 strain was isolated and identified from CSF sample of a paediatric
encephalitis patient in Jakarta, Indonesia. Inoculation of CSF sample from the patient into
Vero cells caused apparent CPE after day 5 (Fig 1B), while inoculation of the serum sample
DENV-3 encephalitis
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caused distinguishable CPE after day 10 (Fig 1C). No changes were observed in the uninfected
Vero cells (Fig 1A). Infection of the Vero cell was confirmed by detection of DENV-3 RNA in
the culture supernatant by pan-flavivirus RT-PCR followed by sequencing of the amplicon.
Furthermore, DENV-3 infection at third passage in C6/36 cells inoculated with CSF sample
was confirmed by detection of intracellular DENV-3 antigen using DENV-3-specific IFA
staining (Fig 1E). The presence of DENV-3 antigen was not observed in uninfected C6/36 cells
(Fig 1D).
By using NGS strategy, 94% of the complete genome was determined from the virus
isolate recovered from Vero cell culture supernatant, while the remaining 5’ and 3’UTR were
sequenced by classical Sanger sequencing. The extreme terminal 5’ and 3’UTR were not con-
firmed independently (i.e. using RACE method) and assumed to be of the same length as the
prototype DENV-3 strain H87. The complete genome of isolate 201610225 consists of 94
nucleotides of 5’UTR, 440 nucleotides of 3’UTR, and a 10,173-nucleotide ORF located from 95
to 10267.
Compared with the prototype DENV-3 strain H87, 46 amino acid changes were found
within the genome of 201610225 (Table 1). Among these, 14 and 20 amino acid changes were
shared with the historical DENV-3 strain collected in Sleman in 1978 (Sleman/78) and Jakarta
in 1988 (den3_88), respectively. Two novel amino acid changes, R3259K and F3369Y, located
in the NS5 protein coding sequence were not observed in any other complete DENV-3
genome. However, when these two changes were mapped to the 3D structure of the NS5 pro-
teins, we found that R3259K and F3369Y are not predicted to significantly affect the physico-
chemical property of the NS5 protein although the R3259K change is located in the protein
Fig 1. Isolation of DENV-3 from CSF and serum samples of an encephalitis patient in Vero and C6/36 mosquito cell cultures. Phase contrast light microscopy of
uninfected monolayer Vero cells (A); infected Vero cells at day 5 after inoculation with CSF sample (B); and infected Vero cells at day 10 after inoculation with serum
sample (C). Indirect immunofluorescent assay (IFA) staining of uninfected C6/36 mosquito cells (D); infected C6/36 mosquito cells at third passage of inoculation with
CSF sample (E). For IFA staining, cells were stained with mouse anti-DENV-3 monoclonal antibody (clone 5D4), followed by FITC-conjugated goat anti-mouse IgG.
Evans blue was used as a counterstain (red). The arrows in B and C point to cytopathic effect (CPE), while the arrows in E point to DENV-infected cells.
https://doi.org/10.1371/journal.pntd.0006198.g001
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Table 1. Amino acid substitutions between 201610225, DENV-3 prototype strain (H87), and DENV-3 Indonesian historical strain (Sleman/78 and den3_88)
genome sequence.
DENV-3
gene
Gene
position a
Polyprotein
position b
Amino acid residue No. of other 784 DENV-3 genome sequences that share
201610225 aa changes (%)H87
(KU050695)
Sleman/78
(AY648961)
den3_88
(AY858038)
201610225
C 65 65 V V I I 35 (4.46)
76 76 G G G R c 4 (0.51)
82 82 K R R R 59 (7.53)
97 97 K R R R 60 (7.65)
pr 55 169 H L L L 209 (26.66)
M 16 221 T T T A 27 (3.44)
37 242 L F F F 60 (7.65)
E 68 348 I V V V 61 (7.78)
124 404 S S S L 30 (3.83)
169 449 A V V V 213 (27.17)
231 511 R K K K 66 (8.42)
301 581 L L L S 25 (3.19)
303 583 T A A A 69 (8.80)
344 624 A A A V c 2 (0.26)
377 657 V V V I 25 (3.19)
479 759 A V A V 225 (28.70)
NS1 96 869 V V V I 15 (1.91)
123 896 I I I V c 3 (0.38)
145 918 S S S N 38 (4.85)
174 947 V M M M 48 (6.12)
256 1029 H Y Y Y 321 (40.94)
NS2A 51 1176 R R R K c 2 (0.26)
55 1180 H H R Q c 1 (0.13)
153 1278 T M M M 50 (6.38)
NS3 60 1533 H H H Y 524 (66.84)
185 1658 K K K R c 6 (0.77)
255 1728 R R K K 35 (4.46)
350 1823 E E D D 25 (3.19)
467 1940 Q Q Q R c 1 (0.13)
NS4A 78 2170 I I I V 21 (2.68)
89 2181 I A V V 60 (7.65)
100 2192 V V V I 596 (76.02)
NS4B 190 2432 L F F F 60 (7.65)
NS5 188 2678 T T T A 46 (5.87)
246 2736 H H H Y 29 (3.70)
274 2764 D D D N c 2 (0.26)
281 2771 K R R R 63 (8.04)
336 2826 M M T T 36 (4.59)
364 2854 R R R K 26 (3.32)
422 2912 R R R K 572 (72.96)
562 3052 Q Q Q R c 7 (0.89)
631 3121 A A A T 38 (4.85)
749 3239 R R K K 327 (41.71)
763 3253 T T A A 61 (7.78)
769 3259 R R R K d 0 (0.00)
879 3369 F F F Y d 0 (0.00)
aAmino acid numbering is given from the start of each gene of DENV-3 prototype strain H87.
bAmino acid numbering is given relative to the complete coding region of DENV-3 prototype strain H87.
cDenotes amino acid changes which were found in relatively few other DENV-3 strains (less than 1% occurrence)
dDenotes amino acid changes which are unique to isolate 201610225
https://doi.org/10.1371/journal.pntd.0006198.t001
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bend structure. Moreover, while the remaining 44 amino acid changes were also observed in
other DENV-3 strains in our complete genome data set, nine amino acid changes were only
found in relatively few other DENV-3 strains (less than 1% occurrence), including G76R
(found in 4 others), A624V (found in 2 others), I896V (found in 3 others), R1176K (found in 2
others), H1180Q (found in 1 others), K1658R (found in 6 others), Q1940R (found in 1 other),
D2764N (found in 2 others), and Q3052R (found in 7 others).
In addition to amino acid changes within the ORF, we also examined the nucleotide changes
that occurred in the 5’UTR and 3’UTR of the neurotropic DENV-3 genome. Compared with
the prototype DENV-3 strain H87, a G to A change at position 62 was observed; this change
was also seen in other DENV-3 strains in our data set. The G62A nucleotide change was found
to be associated with DENV-3 genotype I specifically [25]. No other nucleotide changes were
found in the 5’UTR of our neurotropic DENV-3 genome. The 3’UTR of 201610225 genome has
an insertion of an 11-nucleotide sequence (AGTGAAAAAGA) after position 10275 and seven
nucleotide changes including A10269C, C10294T, G10425A, T10476C, A10504G, T10567G,
and C10585T when compared with the prototype DENV-3 strain H87. The RNA structure of
complete 3’UTR 201610225 was predicted and compared with the strain H87 (Fig 2). The
nucleotide changes present in our isolate were not predicted to alter the two stem-loop (SLI and
SLII), the conserved duplicated dumbbell structures (DBI and DBII), or the essential terminal
structure small hairpin 3’ stem-loop (SHP-3’SL) which are important for viral RNA synthesis
[18]. However, the 11-nucleotide insertion observed in our isolate was predicted to form bigger
stem-loop structure downstream of the stop codon compared with the strain H87. Furthermore,
when we compared these nucleotide insertion and changes to all other DENV-3 3’UTR
sequences, we found that none were unique to isolate 201610225.
The complete ORF of DENV-3 phylogenetic tree generated using the Bayesian MCMC
method showed that 201610225 belongs to genotype I based on Lanciotti et al and Wittke et al
classification [26,27] and is closely related to isolate TB16, KJ30i, and TB55i (GenBank acc. no.
AY858047, AY858042, and AY858048, respectively) sampled in Jakarta, Indonesia in 2004 (Fig
3). This phylogenetic history was supported by high posterior probability values (1.0). Molecu-
lar clock analysis suggested that these strains shared a common ancestor dated from approxi-
mately 1998 (95% HPD: 1996–1999). Furthermore, our phylogenetic tree also indicates that
201610225 was part of Sumatran-Javan clade which includes DENV-3 genotype I strains from
Sumatra, Jawa, and Sulawesi islands in Indonesia as well as strains from Timor Leste (formerly
East Timor) described previously [28]. The time to the most recent common ancestor
(TMRCA) of this Sumatran-Javan clade was approximately 1978 (95% HPD: 1977–1983) sup-
ported by high posterior probability values (1.0). Similar to the complete ORF phylogenetic
tree, MCMC phylogenetic tree based on the envelope gene with additional recent DENV-3
Indonesian and Southeast Asian reference strains suggested that strain 201610225 is closely
related to the same Jakarta strains mentioned above as well as to strains from Bandung (Gen-
Bank acc. no. AY265857) and Semarang (GenBank acc. no. KC589013 and KC589012), Jawa
island, Indonesia (S1 Fig). The TMRCA of this clade based on the envelope region is estimated
to be 1997 (95% HPD: 1996–1998) with high posterior probability values (1.0). The envelope
phylogenetic tree also confirms the classification of our isolate as DENV-3 genotype I. Addi-
tionally, screening for recombination by RDP4 analysis found no evidence of recombination
in 201610225 genome.
Discussion
Over the last five decades, numerous studies have reported DENV-associated neurological
manifestations in prospective and retrospective as well as in outbreak and case report study
DENV-3 encephalitis
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settings [7]. Despite the recent increase in the number of cases of neurological dengue, the
pathogenesis of neurotropism is still controversial and the neurotropic virus are not well char-
acterized, although some studies suggest a direct virus-induced destruction of neurons [29–
31]. The encephalitis case presented here is similar to cases described in some of the earliest
reports of DENV-associated encephalitis/encephalopathy in Indonesia [32–35]. However,
assays to detect virus or antibody were either not performed or not successful in these studies.
Our report describes the isolation and complete genome analysis of DENV-3 from CSF of an
Fig 2. Mfold RNA structure prediction for the complete 3’UTR of DENV-3 prototype strain H87 (KU050695) and the neurotropic DENV-3 201610225
(KY863456). Stop codon (UAA) is indicated with red font in both RNA structure just upstream nucleotide 10268. Nucleotide insertion and changes in isolate 201610225
are indicated with yellow and red circles, respectively. The positions of the nucleotide changes are indicated according to 201610225 nucleotide numbering with H87
nucleotide numbering in parentheses. The two stem-loops (SLI and SLII), two dumbbells (DBI and DBII), and small hairpin 3’ stem-loop (SHP-3’SL) structures are
shown.
https://doi.org/10.1371/journal.pntd.0006198.g002
DENV-3 encephalitis
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encephalitis patient in Jakarta, Indonesia. Although a number of studies have reported the
presence of DENV RNA and infectious virus in the CSF of encephalitis patients, there are only
few published studies detailing the findings on the genetic characteristics of the neurotropic
DENV strains, including one DENV-4 complete genome sequence, one DENV-3 partial cap-
sid-prM sequence, one DENV-3 envelope, and two DENV-2 partial envelope-NS1 sequences
isolated directly from CSF of encephalitis patients [36–39]. To our knowledge, this is the first
complete genome analysis of DENV-3 isolated from CSF in a patient with neurological mani-
festations, underscoring the need for more molecular studies to better characterize neurotropic
DENV strains.
The identification of serotype DENV-3 in an encephalitis case is not unexpected, as DENV-
3, together with DENV-2, appeared to be more frequently associated with encephalitis and
other neurological complications compared with other serotypes [29,37–43,35]. Although all
DENV serotypes are endemic in Indonesia and cycling occurs between DENV serotypes,
DENV-3 has been historically reported as the predominant circulating serotype since 1975
[44]. A meta-analysis study encompassing 15,741 cases of dengue from 31 reports of primary
infections found that these primary infections with DENV-3 are associated with severe cases
under WHO new classification [45], thus emphasizing the need for appropriate clinical con-
sideration for DENV-3 cases.
It is also noteworthy that the patient in this report experienced primary DENV infection as
evidenced by the absence of anti-DENV IgG both in serum and CSF. Antibody-dependent
enhancement (ADE) in secondary DENV infections has been proposed to increase viral repli-
cation leading to over activation of immune response [46]. However, the neurological compli-
cations seen in this patient might be the consequences of direct viral invasion in the CNS,
rather than non-specific immune complications of DENV infection. The finding of DENV in
CSF also supports a more direct cause of viral invasion as with earlier studies [31,36,37]. The
presence of relatively high viral load in the serum compared to CSF is also striking in contrast
to other flaviviruses such as Japanese encephalitis virus and West Nile virus infections, where
viremia is undetectable by the time they invade the CNS [47–49]. Nevertheless, dengue
encephalitis could be due to host genetic or immunologic differences rather than viral muta-
tions although evidence to support this possibility is scarce. Many studies have shown that
dengue disease severity can be influenced by host genetic variation and immune status
[reviewed in 6]. However, these studies did not specifically compare dengue encephalitis and
non-encephalitis patients and further data from dengue encephalitis cases is still needed.
In this study, two unique and nine uncommon amino acid changes were shown to be pres-
ent in isolate 201610225. The two unique amino acid changes in NS5 region (R3259K and
F3369Y) have never been reported before, while the nine uncommon amino acid changes
including G76R (capsid); A624V (envelope); I896V (NS1); R1176K and H1180Q (NS2A);
K1658R and Q1940R (NS3); D2764N and Q3052R (NS5) were found in a few other strains
with complete genomes listed in GenBank. The putative amino acid changes associated with
DENV-3 neurovirulence in mouse [50], including A18S, A54E, F277S, E401K, and T403I were
not found in isolate 201610225. Similarly, the amino acid change in the envelope protein
(E406K) which has been identified as a neurovirulence determinant of DENV-2 and DENV-3
[51,52] was not found in isolate 201610225. Furthermore, no amino acid changes are shared
between isolate 201610225 and partial genome sequences of DENV-3 strains isolated from the
Fig 3. Maximum clade credibility (MCC) tree of 64 complete coding sequences of DENV-3 and the neurotropic DENV-3 isolate 201610225. Horizontal branches are
drawn to scale of estimated year of divergence with tip times reflecting sampling date (year). The coalescent (i.e. divergence) times of key nodes, 95% HPD values, as well
their posterior probability are shown. Strains are labeled as follows: GenBank accession number/country/year. Isolate 201610225 presented here is in bold red font.
GenBank accession number for the complete genome sequence 201610225 is KY863456.
https://doi.org/10.1371/journal.pntd.0006198.g003
DENV-3 encephalitis
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CSF of encephalitis patients described earlier (DENV-3 partial capsid-prM and envelope
sequence; GenBank acc. no. KM024988 and KP893717, respectively). Interestingly however,
amino acid changes F3369Y and K1658R found in our neurotropic DENV-3 were also found
in corresponding position of neurotropic DENV-4 (GenBank acc. no. JX024757) [36]. The
amino acids F3369Y and K1658R shared similar properties; F and Y are aromatic hydrophobic
amino acids with Y being more polar, while K and R are positively-charged polar amino acids
with K being more hydrophobic. Whether these amino acid changes represent genetic deter-
minant of DENV neurovirulence is unknown. Genetic characterization of additional neuro-
tropic DENVs will allow further insights into the role of these unique amino acid changes
found in isolate 201610225. In addition, further studies are warranted to study the virulence of
this isolate in animal models and its tropism for neural cells in vitro.
Complete genome phylogenetic analysis placed the 201610225 strain in the DENV-3 geno-
type I group, reported to be circulating in Indonesia for almost four decades. It has been sug-
gested by Ong et al [28] that the strains from this particular clade are likely to cause another
dengue epidemic if they remain in circulation. Not surprisingly, within the Sumatran-Javan
clade of DENV-3 genotype I, isolate 201610225 was found to be more closely related to isolates
from Jakarta and Singapore than to those from Makassar, a city on eastern Indonesia’s Sula-
wesi island. Together, this result suggests the endemicity of Sumatran-Javan clade of DENV-3
with sustained transmission in Indonesia.
In summary, we described here the isolation and the first complete genome analysis of
DENV-3 from the CSF of an encephalitis patient. Our findings complement those of others in
suggesting the greater pathogenic potential of DENV-3 to cause neurological complications.
Furthermore, DENV should be included in the laboratory diagnostic algorithm for encephali-
tis and other CNS infections especially in dengue endemic areas, despite the challenges in labo-
ratory confirmation as isolation of virus or antibody from CSF is often difficult.
Supporting information
S1 Fig. Maximum clade credibility (MCC) tree of 112 envelope gene sequences of DENV-3
and the neurotropic DENV-3 isolate 201610225. Horizontal branches are drawn to scale of
estimated year of divergence with tip times reflecting sampling date (year). The coalescent (i.e.
divergence) times of key nodes, 95% HPD values, as well their posterior probability are shown.
Strains are labeled as follows: GenBank accession number/country/year. Isolate 201610225
presented here is in bold red font.
(PDF)
S1 Table. List of all available DENV-3 complete genome sequences retrieved from the Gen-
Bank database with known host and country of isolation as of December 6, 2016.
(XLSX)
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